Ectopically expressed intracellular recombinant antibodies, or intrabodies, are powerful tools to visualize proteins and study their function in fixed or living cells. However, many intrabodies are insoluble and aggregate in the reducing environment of the cytosol. To solve this problem, we describe an approach based on GFP-tagged intrabodies. In this protocol, the GFP is used both as a folding-reporter to select correctly folded intrabodies and as a fluorescent tag to localize the scFv and its associated antigen in eukaryotic cells. Starting from a scFv gene cloned in a retroviral vector, we describe retrovirus production, cell line transduction, and soluble intrabody characterization by microscopy and FACS analysis.
Introduction
Intrabodies are recombinant antibody fragments expressed in cells. They have been mainly used to study protein function and localization within live cells. Indeed, an intrabody can modulate the activity of its cognate antigen and thus induce a phenotypic change that will give clues about the protein function within the cell (1-2). As such, intrabodies are analogous to RNAi but at the protein level. In addition, when fused to the green fluorescent protein (GFP), intrabodies become powerful probes to visualize intracellular targets in live cells (3-4). Of interest, intrabodies maintain the high specificity and affinity of the antibody molecule for its antigen, and are thus also able to target a particular protein conformation or posttranslational modification (4).
The most widely used format of intrabodies is the single-chain variable fragment (scFv) since it is the smallest antibody fragment (28 kDa) still containing the full antigenbinding site. ScFvs are made up by joining with a flexible linker the variable domains of the heavy (VH) and the light chain (VL), and are thus encoded by a single gene, contrary to regular antibodies or Fab fragments. This facilitates the cloning of the gene in different vectors for intrabody expression and also avoids dissociation of the two chains within the cell.
Such scFvs are now routinely selected by screening antibody libraries using phage-display in E. coli. Isolated scFvs are then produced in E. coli periplasm or cytoplasm for further in vitro characterization and finally tested, as intrabodies, in an appropriate mammalian cell model.
Despite advances in the development of optimized libraries based on hyperstable frameworks (5-10), the intracellular expression and activity of many scFvs is limited, making the approach still challenging. The reducing environment that pertains in the cytosol and the nucleus of mammalian cells prevents the formation of the two conserved disulphide bridges of the scFv, resulting in a decrease in its stability and folding efficiency. Consequently, only a small proportion of intrabodies is soluble and functional in the cell cytoplasm and, in many cases, intrabodies form insoluble aggregates or are quickly degraded by the proteolytic machinery of the cell.
We describe here an approach to easily identify the most soluble and stable intrabodies by using the GFP as a folding-reporter, as originally proposed in E. coli (11). This allows the visualization of scFv-GFP fusion proteins in live cells, an easy evaluation of intrabody steadystate expression levels, a sensitive detection of protein aggregates, and even in some cases a first evaluation of the intrabody activity in the cell. The approach relies on the fact that during protein synthesis there is a kinetic competition between folding, aggregation and proteolytic degradation. During protein folding, aggregation-prone folding intermediates will have different fates depending on the protein expression level. If over-expressed in the cytoplasm in mammalian cells, the degradation machinery will be overwhelmed and scFv-GFP will accumulate as insoluble and strongly fluorescent aggregates. Conversely, when expressed at low level, the intrabody and its companion GFP will be efficiently degraded, resulting in weakly fluorescent cells ( Fig. 1) (12) . Therefore, an aggregation-prone scFv fused to the GFP can be distinguished by FACS from a soluble one, provided it is expressed at a sufficiently low level to avoid the formation of fluorescent aggregates: the former will give a weak fluorescent signal, whereas expression of the latter will result in strongly fluorescent cells.
To obtain a sufficiently low expression level, we propose to transfer scFv genes by retroviral infection in mammalian cell lines. Using this approach, only a few scFv-GFP genes enter each cell, while transient transfection would result in the transfer of thousands of copies in a single cell. In addition, the intrabody will be stably and evenly expressed by all the cells.
In this chapter, we describe procedures to obtain a low intracellular expression of scFv in eukaryotic cells using retroviral transfection. We detail protocols for retrovirus production 15. 0.01% (v/v) Triton X-100 diluted in PBS. Prepare the day of use using a 10% stock solution (see Note 9).
16. Hoechst 33342 dye solution at 500 µg/mL diluted in water (see Note 10).
17. Prolong (Invitrogen) (see Note 11).
Methods

Retrovirus production
The following protocol assumes that the sequence of the scFv gene has been cloned in a pMSCV retroviral expression vector (7) in frame with the gene encoding the enhanced GFP (Fig. 2) . We describe here a protocol of retrovirus production by transient transfection in the human HEK 293 cell line (see Note 12). Cells are grown in DMEM supplemented with 10% heat-inactivated FCS at 37°C in a 5% CO 2 humidified atmosphere. 
Cell line transduction and selection for stable integration
The following method describes transduction of adherent cell lines, such as HeLa or MCF7.
1. The day prior to infection, plate 1 million of your target cells in a 100 mm dish and incubate them at 37°C (see Note 18).
2. The next day, remove medium, then add 5 mL of fresh medium, 1 mL of viral supernatant (see Note 19) and Polybrene at 4 µg/mL final concentration.
3. Incubate overnight at 37°C. 
Microscopy analysis
1. Using forceps, deposit one 12-mm-diameter glass coverslip per well in a 24-well plate.
2. Plate 25,000 cells/well.
3. Twenty-four to 48 hours later, wash the cells once with PBS.
4. Cover the cells with 300 µL PBS-2% PFA to fix them. Incubate for 10 minutes at room temperature (see Note 23).
Wash the cells 3 times with PBS.
6. Cover the cells with 300 µL of PBS-0.01% Triton X-100 to permeabilize the cells. 
